Mohammed A. Alfuwais

Riyadh, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Decitabine Induces Subtype-Specific Epigenomic Remodeling and Perturbs Age-Associated Regulatory CpGs in Breast Cancer.

Decitabine Induces Subtype-Specific Epigenomic Remodeling and Perturbs Age-Associated Regulatory CpGs in Breast Cancer.

Journal: Cancer informatics
Published: January 07, 2026

Outcomes and timing of laparoscopic cholecystectomy in gallstone disease: A single-center retrospective cohort study.

Outcomes and timing of laparoscopic cholecystectomy in gallstone disease: A single-center retrospective cohort study.

Journal: Medicine
Published: December 04, 2025

Current trends in theranostic applications of extracellular vesicles in cancer.

Current trends in theranostic applications of extracellular vesicles in cancer.

Journal: Frontiers in oncology
Published: March 11, 2025

Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview.

Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview.

Journal: Diagnostics (Basel, Switzerland)
Published: June 06, 2024

Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma.

Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma.

Journal: Biosensors
Published: March 18, 2024

Pediatric Anesthesia Exposure: Decoding Its Neurodevelopmental Implications and Navigating the Nuances.

Pediatric Anesthesia Exposure: Decoding Its Neurodevelopmental Implications and Navigating the Nuances.

Journal: Cureus
Published: March 11, 2024

Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.

Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.

Journal: Nutrients
Published: January 21, 2024

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease.

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease.

Journal: Frontiers in aging neuroscience
Published: April 21, 2023
Showing 1-8 of 8

Last Updated: 09/26/2026